$135 Billion is the total value of PRIMECAP MANAGEMENT CO/CA/'s 300 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ROKU | Exit | ROKU INC | $0 | – | -16,500 | -100.0% | -0.00% | – |
| AVYA | Exit | AVAYA HOLDINGS CORP | $0 | – | -81,100 | -100.0% | -0.00% | – |
| GTX | Exit | GARRETT MOTION INC. | $0 | – | -49,158 | -100.0% | -0.00% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -1,052,300 | -100.0% | -0.00% | – |
| CAR | Exit | AVIS BUDGET GROUP | $0 | – | -80,000 | -100.0% | -0.00% | – |
| NCS | Exit | NCI BUILDING SYSTEMS | $0 | – | -340,000 | -100.0% | -0.00% | – |
| GTTN | Exit | GTT COMMUNICATIONS | $0 | – | -62,400 | -100.0% | -0.00% | – |
| Exit | SAFRAN | $0 | – | -30,000 | -100.0% | -0.00% | – | |
| OMED | Exit | ONCOMED PHARMACEUTICALS | $0 | – | -5,451,400 | -100.0% | -0.00% | – |
| EQIX | Exit | EQUINIX | $0 | – | -20,700 | -100.0% | -0.01% | – |
| PEP | Exit | PEPSICO INC | $0 | – | -200,000 | -100.0% | -0.02% | – |
| TRV | Exit | TRAVELERS COMPANIES INC. | $0 | – | -399,775 | -100.0% | -0.04% | – |
| ELLI | Exit | ELLIE MAE | $0 | – | -2,711,045 | -100.0% | -0.20% | – |
| DWDP | Exit | DOWDUPONT INC | $0 | – | -6,571,310 | -100.0% | -0.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LILLY ELI & CO | 42 | Q3 2023 | 10.5% |
| BIOGEN INC. | 42 | Q3 2023 | 6.8% |
| AMGEN INC. | 42 | Q3 2023 | 5.3% |
| MICROSOFT CORP. | 42 | Q3 2023 | 4.2% |
| ADOBE SYSTEMS INCORPORATED | 42 | Q3 2023 | 4.1% |
| TEXAS INSTRS. INC. | 42 | Q3 2023 | 3.5% |
| FEDEX CORP | 42 | Q3 2023 | 3.3% |
| SOUTHWEST AIRLS CO | 42 | Q3 2023 | 3.8% |
| NOVARTIS AG ADR | 42 | Q3 2023 | 2.7% |
| MICRON TECHNOLOGY INC | 42 | Q3 2023 | 2.8% |
View PRIMECAP MANAGEMENT CO/CA/'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NEKTAR THERAPEUTICS | July 07, 2023 | 8,149,876 | 4.3% |
| STANDARD BIOTOOLS INC. | July 07, 2023 | 3,220,917 | 4.1% |
| Calithera Biosciences, Inc. | February 09, 2023 | 401,080 | 8.2% |
| CERUS CORP | January 09, 2023 | 8,849,600 | 5.0% |
| COMSCORE, INC. | January 09, 2023 | 2,883,435 | 3.1% |
| STRATASYS LTD. | December 08, 2022 | 3,176,499 | 4.8% |
| Wave Life Sciences Ltd. | December 08, 2022 | 4,225,908 | 4.9% |
| NN INC | November 09, 2022 | 1,763,640 | 4.0% |
| AXCELIS TECHNOLOGIES INC | October 07, 2022 | 1,649,466 | 5.0% |
| Epizyme, Inc.Sold out | September 08, 2022 | 0 | 0.0% |
View PRIMECAP MANAGEMENT CO/CA/'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View PRIMECAP MANAGEMENT CO/CA/'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.